BioCardia, Inc. BCDA
0.90 USD +0.05 (+6.19%)
At closeNov 10, 2026, 5:37 AM EST
0.95 +0.05 +5.25%
Pre-market · Nov 10, 5:37 AM ET
0.85 Day range 0.96
0.75 52-week range 1.80
- YTD
- -27.79%
- 1 year
- -30.57%
Benzinga news
benzinga.com BioCardia Announces Completion Of Process With Japan's Pharmaceuticals And Medical Devices Agency Seeking Regulator Nod For Its CardiAMP Cell Therapy system To Treat Ischemic Heart Failure BioCardia®, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that it has completed the process…
benzinga.com BioCardia Receives FDA Acceptance For Its Pre-Submission Package For Marketing Clearance Of Its Helix Catheter For Therapeutic And Diagnostic Agent Delivery BioCardia, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its…